Related Experiment Video
Updated: Dec 5, 2025

Determining Immune System Suppression versus CNS Protection for Pharmacological Interventions in Autoimmune Demyelination
Published on: September 12, 2016
Drugs for Multiple Sclerosis Activate Natural Killer Cells: Do They Protect Against COVID-19 Infection?
Mena Al-Ani1, Noha Mousaad Elemam1, Jennifer Elisabeth Hundt2
1Department of Clinical Sciences, College of Medicine and the Immuno-Oncology Group, Sharjah Institute for Medical Research, University of Sharjah, Sharjah 27272, United Arab Emirates.
Abstract:
COVID-19 infection caused by the newly discovered coronavirus severe acute respiratory distress syndrome virus-19 (SARS-CoV-2) has become a pandemic issue across the globe. There are currently many investigations taking place to look for specific, safe and potent anti-viral agents. Upon transmission and entry into the human body, SARS-CoV-2 triggers multiple immune players to be involved in the fight against the viral infection. Amongst these immune cells are NK cells that possess robust antiviral activity, and which do not require prior sensitization. However, NK cell count and activity were found to be impaired in COVID-19 patients and hence, could become a potential therapeutic target for COVID-19. Several drugs, including glatiramer acetate (GA), vitamin D3, dimethyl fumarate (DMF), monomethyl fumarate (MMF), natalizumab, ocrelizumab, and IFN-β, among others have been previously described to increase the biological activities of NK cells especially their cytolytic potential as reported by upregulation of CD107a, and the release of perforin and granzymes. In this review, we propose that such drugs could potentially restore NK cell activity allowing individuals to be more protective against COVID-19 infection and its complications.
Insights
Certain drugs may restore natural killer (NK) cell activity impaired by severe acute respiratory distress syndrome coronavirus-19 (SARS-CoV-2). This could enhance protection against COVID-19 infection and its complications.
Area of Science:
- Immunology
- Virology
- Pharmacology
Background:
- Severe acute respiratory distress syndrome coronavirus-19 (SARS-CoV-2) infection impairs natural killer (NK) cell function.
- NK cells are crucial for innate antiviral immunity and do not require prior sensitization.
- Restoring NK cell activity presents a potential therapeutic strategy for COVID-19.
Purpose of the Study:
- To review existing drugs that enhance NK cell activity.
- To propose these drugs as potential therapeutics to restore NK cell function in COVID-19 patients.
Main Methods:
- Literature review of studies on NK cell function and drug effects.
- Analysis of drugs known to modulate NK cell activity, including glatiramer acetate, vitamin D3, dimethyl fumarate, monomethyl fumarate, natalizumab, ocrelizumab, and IFN-β.
- Examination of NK cell activation markers such as CD107a, perforin, and granzymes.
Main Results:
- Several drugs have demonstrated the ability to enhance NK cell biological activities.
- These drugs can increase NK cell cytolytic potential, evidenced by upregulation of CD107a and release of perforin and granzymes.
- Impaired NK cell function in COVID-19 patients highlights them as a therapeutic target.
Conclusions:
- Drugs that enhance NK cell activity may offer a novel approach to combatting SARS-CoV-2 infection.
- Restoring NK cell function could improve patient outcomes and reduce COVID-19 complications.
- Further research into these immunomodulatory drugs is warranted for COVID-19 treatment.
More Related Videos
Related Concept Videos
Immune Response Against Viral Pathogens
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
Cytotoxic T Cells-mediated Immune Response
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
Immune Surveillance by NK Cells and Phagocytes
Natural Killer Cells: The Fast Responders
NK cells are large granular lymphocytes found in the blood and lymphatic system. These...
T Cell Types and Functions
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Cells of the Innate Immune Response
Phagocytes
Phagocytes police the peripheral tissues by removing cellular debris and responding to the invasion of foreign substances or pathogens. Many phagocytes attack and remove microorganisms even before lymphocytes detect them. The human body has two general...

